Hydrophobic benzoic acids as inhibitors of influenza neuraminidase

被引:38
|
作者
Atigadda, VR
Brouillette, WJ [1 ]
Duarte, F
Babu, YS
Bantia, S
Chand, P
Chu, NM
Montgomery, JA
Walsh, DA
Sudbeck, E
Finley, J
Air, GM
Luo, M
Laver, GW
机构
[1] Univ Alabama, Dept Chem, Birmingham, AL 35294 USA
[2] Univ Alabama, Ctr Macromol Crystallog, Birmingham, AL 35294 USA
[3] BioCryst Pharmaceut Inc, Birmingham, AL 35244 USA
[4] Univ Oklahoma, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA
[5] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia
关键词
neuraminidase; influenza virus; sialidase; structure-based drug design;
D O I
10.1016/S0968-0896(99)00197-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuraminidase (NA) plays a critical role in the life cycle of influenza virus and is a target for new therapeutic agents. A new benzoic acid inhibitor (11) containing a lipophilic side chain at C-3 and a guanidine at C-5 was synthesized. The X-ray structure of 4-(N-acetylamino)-5-guanidino-3-(3-pentyloxy)benzoic acid in complex with NA revealed that the lipophilic side chain binds in a newly created hydrophobic pocket formed by the movement of Glu 278 to interact with Arg 226, whereas the guanidine of 11 interacts In a negatively charged pocket created by Asp 152, Glu 120 and Glu 229. Compound 11 was highly selective for type A (H2N2) influenza NA (IC50 1 mu M) over type B (B/Lee/40) influenza NA (IC50 500 mu M). (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2487 / 2497
页数:11
相关论文
共 50 条
  • [1] Novel benzoic acids as influenza neuraminidase inhibitors.
    Brouillette, WJ
    Bajpai, SN
    Finley, JB
    Luo, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U1011 - U1011
  • [2] Substituted benzoic acids as inhibitors of influenza neuraminidase.
    Duarte, FJ
    Babu, YS
    Bantia, S
    Chand, P
    Chu, N
    Montgomery, JA
    Walsh, DA
    Luo, M
    Brouillette, WJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 276 - MEDI
  • [3] BENZOIC-ACID INHIBITORS OF INFLUENZA-VIRUS NEURAMINIDASE
    LUO, M
    JEDRZEJAS, MJ
    SINGH, S
    WHITE, CL
    BROUILLETTE, WJ
    AIR, GM
    LAVER, WG
    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1995, 51 : 504 - 510
  • [4] Structure-based benzoic acid inhibitors of influenza neuraminidase.
    Brouillette, WJ
    Atigadda, VR
    Duarte, FJ
    Luo, M
    Montgomery, JA
    Walsh, DA
    Chand, P
    Bantia, S
    Chu, N
    Babu, YS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 251 - MEDI
  • [5] Neuraminidase inhibitors for influenza
    Krumholz, Harlan M.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [6] Influenza neuraminidase mutations and resistance to neuraminidase inhibitors
    Xu, Jiapeng
    Luo, Qiting
    Huang, Yuanyuan
    Li, Jieyu
    Ye, Wei
    Yan, Ran
    Zhou, Xinrui
    He, Zhendan
    Liu, Ge
    Zhu, Qinchang
    EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
  • [7] Neuraminidase inhibitors for treatment of influenza
    Zwillenberg, Marc
    Tang, Eric
    Quaas, Joshua
    ACADEMIC EMERGENCY MEDICINE, 2021, 28 (10) : 1195 - 1197
  • [8] Neuraminidase Inhibitors and Influenza Infection
    Osthoff, Michael
    Erb, Stefan
    JAMA INTERNAL MEDICINE, 2016, 176 (03) : 415 - 415
  • [9] Influenza A, pregnancy and neuraminidase inhibitors
    Montane, Eva
    Lecumberri, Josep
    Luisa Pedro-Botet, Maria
    MEDICINA CLINICA, 2011, 136 (15): : 688 - 693
  • [10] Neuraminidase inhibitors in the therapy of influenza
    Fladerer, P
    Wenisch, C
    ACTA MEDICA AUSTRIACA, 2000, 27 (05) : 133 - 140